Effects of heliox and non-invasive neurally adjusted ventilatory assist (NIV-NAVA) in preterm infants

Abstract Due to its unique properties, helium–oxygen (heliox) mixtures may provide benefits during non-invasive ventilation, however, knowledge regarding the effects of such therapy in premature infants is limited. This is the first report of heliox non-invasive neurally adjusted ventilatory assist...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Natalia Neumann-Klimasińska, T. Allen Merritt, Jennifer Beck, Izabela Miechowicz, Marta Szymankiewicz-Bręborowicz, Tomasz Szczapa
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/fbf2a8f1aa4a42978fda3c2360e17d16
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fbf2a8f1aa4a42978fda3c2360e17d16
record_format dspace
spelling oai:doaj.org-article:fbf2a8f1aa4a42978fda3c2360e17d162021-12-02T14:53:34ZEffects of heliox and non-invasive neurally adjusted ventilatory assist (NIV-NAVA) in preterm infants10.1038/s41598-021-95444-22045-2322https://doaj.org/article/fbf2a8f1aa4a42978fda3c2360e17d162021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-95444-2https://doaj.org/toc/2045-2322Abstract Due to its unique properties, helium–oxygen (heliox) mixtures may provide benefits during non-invasive ventilation, however, knowledge regarding the effects of such therapy in premature infants is limited. This is the first report of heliox non-invasive neurally adjusted ventilatory assist (NIV-NAVA) ventilation applied in neonates born ≤ 32 weeks gestational age. After baseline NIV-NAVA ventilation with a standard mixture of air and oxygen, heliox was introduced for 3 h, followed by 3 h of air-oxygen. Heart rate, peripheral capillary oxygen saturation, cerebral oxygenation, electrical activity of the diaphragm (Edi) and selected ventilatory parameters (e.g., respiratory rate, peak inspiratory pressure) were continuously monitored. We found that application of heliox NIV-NAVA in preterm infants was feasible and associated with a prompt and significant decrease of Edi suggesting reduced respiratory effort, while all other parameters were stable throughout the study, and had similar values during heliox and air-oxygen ventilation. This therapy may potentially enhance the efficacy of non-invasive respiratory support in preterm neonates and reduce the number of infants progressing to ventilatory failure.Natalia Neumann-KlimasińskaT. Allen MerrittJennifer BeckIzabela MiechowiczMarta Szymankiewicz-BręborowiczTomasz SzczapaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Natalia Neumann-Klimasińska
T. Allen Merritt
Jennifer Beck
Izabela Miechowicz
Marta Szymankiewicz-Bręborowicz
Tomasz Szczapa
Effects of heliox and non-invasive neurally adjusted ventilatory assist (NIV-NAVA) in preterm infants
description Abstract Due to its unique properties, helium–oxygen (heliox) mixtures may provide benefits during non-invasive ventilation, however, knowledge regarding the effects of such therapy in premature infants is limited. This is the first report of heliox non-invasive neurally adjusted ventilatory assist (NIV-NAVA) ventilation applied in neonates born ≤ 32 weeks gestational age. After baseline NIV-NAVA ventilation with a standard mixture of air and oxygen, heliox was introduced for 3 h, followed by 3 h of air-oxygen. Heart rate, peripheral capillary oxygen saturation, cerebral oxygenation, electrical activity of the diaphragm (Edi) and selected ventilatory parameters (e.g., respiratory rate, peak inspiratory pressure) were continuously monitored. We found that application of heliox NIV-NAVA in preterm infants was feasible and associated with a prompt and significant decrease of Edi suggesting reduced respiratory effort, while all other parameters were stable throughout the study, and had similar values during heliox and air-oxygen ventilation. This therapy may potentially enhance the efficacy of non-invasive respiratory support in preterm neonates and reduce the number of infants progressing to ventilatory failure.
format article
author Natalia Neumann-Klimasińska
T. Allen Merritt
Jennifer Beck
Izabela Miechowicz
Marta Szymankiewicz-Bręborowicz
Tomasz Szczapa
author_facet Natalia Neumann-Klimasińska
T. Allen Merritt
Jennifer Beck
Izabela Miechowicz
Marta Szymankiewicz-Bręborowicz
Tomasz Szczapa
author_sort Natalia Neumann-Klimasińska
title Effects of heliox and non-invasive neurally adjusted ventilatory assist (NIV-NAVA) in preterm infants
title_short Effects of heliox and non-invasive neurally adjusted ventilatory assist (NIV-NAVA) in preterm infants
title_full Effects of heliox and non-invasive neurally adjusted ventilatory assist (NIV-NAVA) in preterm infants
title_fullStr Effects of heliox and non-invasive neurally adjusted ventilatory assist (NIV-NAVA) in preterm infants
title_full_unstemmed Effects of heliox and non-invasive neurally adjusted ventilatory assist (NIV-NAVA) in preterm infants
title_sort effects of heliox and non-invasive neurally adjusted ventilatory assist (niv-nava) in preterm infants
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/fbf2a8f1aa4a42978fda3c2360e17d16
work_keys_str_mv AT natalianeumannklimasinska effectsofhelioxandnoninvasiveneurallyadjustedventilatoryassistnivnavainpreterminfants
AT tallenmerritt effectsofhelioxandnoninvasiveneurallyadjustedventilatoryassistnivnavainpreterminfants
AT jenniferbeck effectsofhelioxandnoninvasiveneurallyadjustedventilatoryassistnivnavainpreterminfants
AT izabelamiechowicz effectsofhelioxandnoninvasiveneurallyadjustedventilatoryassistnivnavainpreterminfants
AT martaszymankiewiczbreborowicz effectsofhelioxandnoninvasiveneurallyadjustedventilatoryassistnivnavainpreterminfants
AT tomaszszczapa effectsofhelioxandnoninvasiveneurallyadjustedventilatoryassistnivnavainpreterminfants
_version_ 1718389487342452736